About
Epidemico is an informatics company established in 2007 that combines innovative data acquisition and analysis technologies with public health expertise. Epidemico delivers sophisticated surveillance systems and consumer-centric engagement tools. We provide early insights, continuous monitoring and consumer engagement for a wide range of population health domains, including disease outbreaks, drug safety, supply chain vulnerabilities, and more. Epidemico is known for pioneering global population health solutions that radically disrupt traditional detection, reporting, and engagement systems.
Epidemico is a commercial spinoff of Boston Children’s Hospital, Harvard Medical School and the Massachusetts Institute of Technology. Our suite of cloud-based solutions serve as trusted resources for the public, government officials, life science, financial and Fortune 500 companies both in the US and internationally. Several products are also directly supported by government entities such as the CDC, FDA and HHS. The company’s work has been nationally recognized by the Smithsonian and the Library of Congress as well as media such as the New York Times, NBC and CNN. Epidemico is a wholly owned subsidiary of Booz Allen Hamilton, headquartered in Boston, Massachusetts.
The Epidemico team is comprised of industry recognized epidemiologists and health leaders.
